The association was validated for IL-6 (HR = 1.25, 95% CI 1.08–1.46) and IL-15 (HR = 2.23, 95% CI 1.48–3.35) in an independent cohort adjusting for PS, tumor location, and stage. The gene discussed is IL15; the disease is neoplasm.